Utah’s new stem cell law undermines FDA’s authority

The state of Utah has just enacted a law permitting patients to receive medical treatments using placental stem cells without formal approval by the United States’ federal regulatory body, the Food and Drug Administration (FDA). Some experts are worried that this will undermine the FDA’s authority to regulate drugs and other medical treatments. Furthermore, what is also concerning is that other states may follow suit. The bill, “Placental Tissue Amendment Bill “, part of SB 0199, passed in both houses of the Utah State Legislature in February and was signed into law in March by Governor Spencer Cox. It will take effect on 1 May 2024.